MVJ-31420-83326
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 484 / MI
- Registered
- 2021-11-17
- Relationship
- Child or adolescent in my care
- Guardian
- 6XS-30446-64015
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-16
Dose 1 — Pfizer-BioNTech
-
2021-11-17
Registered in v-safe
-
2021-11-18
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny nose, but probably not relatedMedDRA releases: 2024-11 · check-in free text available
- 2021-11-19
- 2021-11-21
- 2021-11-22
- 2021-11-25
- 2021-12-02
-
2021-12-18
Dose 2 — Pfizer-BioNTech
- 2021-12-18
-
2021-12-19
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-12-20
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · ChillsAdult check-in
- 2021-12-23
- 2021-12-25
- 2022-01-03
- 2022-01-11
- 2022-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-16 | Pfizer-BioNTech | No |
| 2 | 2021-12-18 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Runny nose, but probably not related
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release